The mathematics of random mutation and natural selection for multiple simultaneous selection pressures and the evolution of antimicrobial drug resistance

Abstract

The random mutation and natural selection phenomenon act in a mathematically predictable behavior, which when understood leads to approaches to reduce and prevent the failure of the use of these selection pressures when treating infections and cancers. The underlying principle to impair the random mutation and natural selection phenomenon is to use combination therapy, which forces the population to evolve to multiple selection pressures simultaneously that invoke the multiplication rule of probabilities simultaneously as well. Recently, it has been seen that combination therapy for the treatment of malaria has failed to prevent the emergence of drug‐resistant variants. Using this empirical example and the principles of probability theory, the derivation of the equations describing this treatment failure is carried out. These equations give guidance as to how to use combination therapy for the treatment of cancers and infectious diseases and prevent the emergence of drug resistance. Copyright © 2016 John Wiley & Sons, Ltd.

Spatio-Genetic and phenotypic modelling elucidates resistance and re-sensitisation to treatment in heterogeneous melanoma

“…The vast majority of existing, quantitative models of drug resistance are based on discrete stochastic mechanisms of evolution, which fail to take into account the intermediary stages and continuous nature of phenotypic development 5 [1,2,3,4].…”

Malaria and Other Infectious Diseases, Suppression of the Evolution of Drug Resistance

“…The de novo evolution of drug resistance by rmns is discussed in [4,5]. Though in the Rogers study they do not include subjects with hyperparasitemia (250,000 parasites/mm 3 ), 100,000 parasites/mm 3 still gives rise to huge population sizes which were the upper limit used in the study.…”

Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex

“…Generally speaking, as the number of phages targeting distinct receptors in a given polyphage cocktail increases, the probability of the appearance of an outgrowth that is simultaneously resistant to all of these phages decreases rapidly, regardless of the nature of the receptors that the phages target. All therapeutic and agricultural applications of phages should therefore ideally employ polyphage cocktails with as large a number of phages as possible, in order to reduce the risk of the occurrence of phage resistance [ 165 , 178 , 201 , 232 ]. This principle is well established in modern phage therapy, since it is identical to the one that has been used to guide the successful development of chemical antimicrobial and antiviral cocktails since at least the late 1980s [ 232 , 233 ].…”

“…All therapeutic and agricultural applications of phages should therefore ideally employ polyphage cocktails with as large a number of phages as possible, in order to reduce the risk of the occurrence of phage resistance [ 165 , 178 , 201 , 232 ]. This principle is well established in modern phage therapy, since it is identical to the one that has been used to guide the successful development of chemical antimicrobial and antiviral cocktails since at least the late 1980s [ 232 , 233 ]. Consequently, the field is rife with phage therapy trials employing polyphage cocktails, including several successful human trials, with authors consistently reporting the predictable superiority of these cocktails over monophage therapy [ 135 , 172 , 182 , 187 , 193 , 195 , 196 , 213 , 234 , 235 , 236 , 237 , 238 ].…”